27 results
Keyword Everolimus Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Afinitor
Date of authorisation: 02/08/2009, Revision: 23, Authorised, Last updated: 09/04/2019report Afinitor everolimus Procedure No.: EMEA/H/C/001038/II/0020 … Presentations: Afinitor everolimus See Annex A The following … cells11,12,13. Coadministration of everolimus and AI in breast cancer cells … -
List item
Human medicine European public assessment report (EPAR): Votubia
Date of authorisation: 02/09/2011,
, Revision: 24, Authorised, Last updated: 04/09/2018
EMEA/H/C/002311 Votubia (everolimus) An overview of Votubia … contains the active substance everolimus. Tuberous sclerosis is … Votubia (Votubia (everolimus) EMA/229443/2018 Page … -
List item
Human medicine European public assessment report (EPAR): Kisplyx (updated)
Date of authorisation: 25/08/2016,
, 
, Revision: 10, Authorised, Last updated: 12/11/2019
another cancer medicine called everolimus. Kisplyx contains the active … combination with 5 mg of everolimus once a day. The dose of Kisplyx … and the medicine containing everolimus. Kisplyx EMA/577485/2016 … -
List item
Human medicine European public assessment report (EPAR): Cabometyx (updated)
Date of authorisation: 09/09/2016,, , Revision: 6, Authorised, Last updated: 11/11/2019
survival (PFS) compared with everolimus: PFS was 7.4 months with Cabometyx … Cabometyx versus 3.8 months with everolimus [HR=0.58 (0.45, 0.74), p … with the cancer medicine everolimus. Patients treated with Cabometyx … -
List item
Human medicine European public assessment report (EPAR): Opdivo
Date of authorisation: 19/06/2015,, Revision: 28, Authorised, Last updated: 28/10/2019
Opdivo was compared with everolimus (another cancer medicine … months for patients given everolimus. One main study involving … -
List item
Human medicine European public assessment report (EPAR): Inlyta (updated)
Date of authorisation: 03/09/2012, Revision: 12, Authorised, Last updated: 22/11/2019 -
List item
Human medicine European public assessment report (EPAR): Votrient (updated)
Date of authorisation: 14/06/2010, Revision: 22, Authorised, Last updated: 25/11/2019 -
List item
Human medicine European public assessment report (EPAR): Kisqali
Date of authorisation: 22/08/2017,, Revision: 2, Authorised, Last updated: 16/10/2019
-
List item
Human medicine European public assessment report (EPAR): Xermelo (updated)
Date of authorisation: 17/09/2017,, , Revision: 8, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Fotivda (updated)
Date of authorisation: 24/08/2017,, Revision: 4, Authorised, Last updated: 28/11/2019
-
List item
Human medicine European public assessment report (EPAR): Scenesse (updated)
Date of authorisation: 22/12/2014,, , 
, Revision: 5, Authorised, Last updated: 26/11/2019
-
List item
Human medicine European public assessment report (EPAR): Nexavar (updated)
Date of authorisation: 19/07/2006,, Revision: 28, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Opsumit
Date of authorisation: 20/12/2013,, Revision: 14, Authorised, Last updated: 29/10/2019
-
List item
Human medicine European public assessment report (EPAR): Lutathera
Date of authorisation: 26/09/2017,, , Revision: 2, Authorised, Last updated: 02/04/2019
-
List item
Human medicine European public assessment report (EPAR): Ibrance
Date of authorisation: 09/11/2016,, Revision: 8, Authorised, Last updated: 08/07/2019
-
List item
Human medicine European public assessment report (EPAR): Rapamune
Date of authorisation: 13/03/2001, Revision: 39, Authorised, Last updated: 22/07/2019 -
List item
Human medicine European public assessment report (EPAR): Zydelig
Date of authorisation: 18/09/2014, Revision: 15, Authorised, Last updated: 20/08/2019 -
List item
Human medicine European public assessment report (EPAR): Faslodex
Date of authorisation: 09/03/2004, Revision: 20, Authorised, Last updated: 14/05/2019 -
List item
Human medicine European public assessment report (EPAR): Stivarga
Date of authorisation: 26/08/2013, Revision: 15, Authorised, Last updated: 15/10/2019 -
List item
Human medicine European public assessment report (EPAR): Emend
Date of authorisation: 11/11/2003, Revision: 24, Authorised, Last updated: 12/06/2018 -
List item
Human medicine European public assessment report (EPAR): Ketoconazole HRA
Date of authorisation: 18/11/2014,, , , Revision: 9, Authorised, Last updated: 18/09/2019
-
List item
Human medicine European public assessment report (EPAR): Imbruvica
Date of authorisation: 21/10/2014,, Revision: 16, Authorised, Last updated: 04/11/2019
-
List item
Human medicine European public assessment report (EPAR): Alecensa
Date of authorisation: 16/02/2017,, Revision: 7, Authorised, Last updated: 14/09/2018
-
List item
Human medicine European public assessment report (EPAR): Zelboraf
Date of authorisation: 17/02/2012, Revision: 18, Authorised, Last updated: 23/08/2018 -
List item
Human medicine European public assessment report (EPAR): Tagrisso
Date of authorisation: 01/02/2016,, , Revision: 9, Authorised, Last updated: 23/10/2019